Full name
EMERGOPHARM SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
uses securityreCAPTCHA
32.50.Z - Production of medical devices, instruments, and products, including dental products
20.42.Z - Manufacture of cosmetics and toilet preparations
21.10.Z - Manufacture of basic pharmaceutical products
21.20.Z - Manufacture of pharmaceutical preparations and other pharmaceutical products
46.45.Z - Wholesale trade of perfumes and cosmetics
46.46.Z - Wholesale trade of pharmaceutical and medical products
46.75.Z - Wholesale trade
47.73.Z - Retail sale of pharmaceutical products
47.74.Z - Retail sale of medical and orthopedic products
47.75.Z - Retail sale of cosmetics and toiletries
2021 | 2022 | 2023 | ||
---|---|---|---|---|
K PLN | K PLN | K PLN | % | |
Profit (loss) on sale | -8,5 | -3,5 | -4,6 | -30,3 |
Gross profit (loss) | -8,5 | 696,9 | 84,9 | -87,8 |
EBITDA | ||||
Short time liabilities | 391,2 | 344,5 | 345,2 | 0,2 |
Other operating costs | 0 | 0 | 0 | -100 |
Equity capital | -234,2 | 462,8 | -81,3 | -117,6 |
Operating profit (EBIT) | -8,5 | -3,5 | -4,6 | -32 |
Assets | 157 | 807,2 | 263,9 | -67,3 |
Net profit (loss) | -93,7 | 696,9 | 84,9 | -87,8 |
Cash | 141,5 | 791,1 | 3,1 | -99,6 |
Net income from sale | ||||
Liabilities and provisions for liabilities | 391,2 | 344,5 | 345,2 | 0,2 |
Working assets | 141,5 | 791,7 | 248,4 | -68,6 |
Other income costs | 0 | 0,1 | 0 | -100 |
Depreciation | ||||
% | % | % | p.p. | |
Profitability of capital | 40 | 150,6 | -104,4 | -255 |
Equity capital to total assets | -149,2 | 57,3 | -30,8 | -88,1 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | ||||
Current financial liquidity indicator | 0.36172157526016235 | 2.298501491546631 | 0.7194672226905823 | -1,6 |
Net dept to EBITDA |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane